CoChat

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent

Open access
Miao, Shuang, He, Qianqian, Li, Chen, Wu, Yan, Liu, Mengshan, Chen, Yongshou, Qi, Shizhou, Gong, Kaikai · 2022 · Pharmaceutical Biology

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Abstract

Context Alzheimer’s disease (AD) is a neurodegenerative disorder that affects millions of people worldwide. Acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) are promising therapeutic targets for AD.Objective To evaluate the inhibitory effects of aaptamine on two cholinesterases and investigate the in vivo therapeutic effect on AD in a zebrafish model.Materials and methods Aaptamine was isolated from the sponge Aaptos suberitoides Brøndsted (Suberitidae). Enzyme inhibition, kinetic analysis, surface plasmon resonance (SPR) and molecular docking assays were used to determine its inhibitory effect on AChE and BuChE in vitro. Zebrafish were divided into six groups: control, model, 8 μM donepezil, 5 , 10 and 20 μM aaptamine. After three days of drug treatment, the behaviour assay was performed.Results The IC50 values of aaptamine towards AChE and BuChE were 16.0 and 4.6 μM. And aaptamine directly inhibited the two cholinesterases in the mixed inhibition type, with Ki values of 6.96 ± 0.04 and 6.35 ± 0.02 μM, with Kd values of 87.6 and 10.7 μM. Besides, aaptamine interacts with the crucial anionic sites of AChE and BuChE. In vivo studies indicated that the dyskinesia recovery rates of 5 , 10 and 20 μM aaptamine group were 34.8, 58.8 and 60.0%, respectively, and that of donepezil was 63.7%.Discussion and conclusions Aaptamine showed great potential to exert its anti-AD effects by directly inhibiting the activities of AChE and BuChE. Therefore, this study identified a novel medicinal application of aaptamine and provided a new structural scaffold for the development of anti-AD drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/13880209.2022.2102657

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Chemical structure of aaptamine.
Figure 1. Chemical structure of aaptamine.CC BY · PubMed Central
Figure 2. Dose-response and IC50 values of aaptamine and donepezil against AChE and BuChE.
Figure 2. Dose-response and IC50 values of aaptamine and donepezil against AChE and BuChE.CC BY · PubMed Central
Figure 3. (A) The binding model between aaptamine and AChE. (B) Binding model between aaptamine and BuChE. Orange dashed line: π–π conjugate effect; Yellow dashed line: hydrogen bond. Yellow sticks structure: compound aaptamine; Green sticks structure: protein AChE; Magenta sticks structure: protein BuChE.
Figure 3. (A) The binding model between aaptamine and AChE. (B) Binding model between aaptamine and BuChE. Orange dashed line: π–π conjugate effect; Yellow dashed line: hydrogen bond. Yellow sticks structure: compound aaptamine; Green sticks structure: protein AChE; Magenta sticks structure: protein BuChE.CC BY · PubMed Central
Figure 4. (A) Lineweaver–Burk plot for the inhibition of AChE by aaptamine at different concentrations for substrate ATChI. (B) Secondary plot for calculation of the steady-state inhibition constant (Ki = 1.74 ± 0.04 μM against AChE) of aaptamine. (C) Lineweaver–Burk plot for the inhibition of BuChE by aaptamine at different concentrations for substrate BTChI. (D) Secondary plot for calculation of the steady-state inhibition constant (Ki = 1.59 ± 0.02 μM against BuChE) of aaptamine.
Figure 4. (A) Lineweaver–Burk plot for the inhibition of AChE by aaptamine at different concentrations for substrate ATChI. (B) Secondary plot for calculation of the steady-state inhibition constant (Ki = 1.74 ± 0.04 μM against AChE) of aaptamine. (C) Lineweaver–Burk plot for the inhibition of BuChE by aaptamine at different concentrations for substrate BTChI. (D) Secondary plot for calculation of the steady-state inhibition constant (Ki = 1.59 ± 0.02 μM against BuChE) of aaptamine.CC BY · PubMed Central
Figure 5. (A) Biacore analysis of aaptamine binding to AChE. (B) Steady state of affinity fitting of aaptamine – AChE interaction. (C) Biacore analysis of aaptamine binding to BuChE. (D) Steady state of affinity fitting of aaptamine – BuChE interaction.
Figure 5. (A) Biacore analysis of aaptamine binding to AChE. (B) Steady state of affinity fitting of aaptamine – AChE interaction. (C) Biacore analysis of aaptamine binding to BuChE. (D) Steady state of affinity fitting of aaptamine – BuChE interaction.CC BY · PubMed Central
Figure 6. (A,B) The effect of aaptamine on motility distance of AD zebrafish ###p < 0.001 vs. Control group, **p < 0.01 vs. AlCl3 group. (C,D) Effect of aaptamine on speed change in AD zebrafish. ###p < 0.001 vs. Control group, **p < 0.01 vs. AlCl3 group.
Figure 6. (A,B) The effect of aaptamine on motility distance of AD zebrafish ###p < 0.001 vs. Control group, **p < 0.01 vs. AlCl3 group. (C,D) Effect of aaptamine on speed change in AD zebrafish. ###p < 0.001 vs. Control group, **p < 0.01 vs. AlCl3 group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 33

Metadata

Authors
Miao, S., He, Q., Li, C., Wu, Y., Liu, M., Chen, Y., Qi, S., & Gong, K.
Affiliations
  • Binzhou Medical University (CN)
  • Wuhan Institute of Technology (CN)
Corresponding author
  • Qi, Shizhou
  • Gong, Kaikai
Venue
Pharmaceutical Biology
Published
2022-08-14
Volume
60
Issue
1
Pages
1502-1510
ISSN
  • 0925-1618 (ISSN-L)
  • 1388-0209
  • 1744-5116
OpenAlex
W4291471200
Cited by
29
References
48
Citations by year
2026: 5 · 2025: 10 · 2024: 10 · 2023: 4
FWCI
3.59
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutical Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81903537, 31900441, 81903102)
  • Natural Science Foundation of Shandong Province (ZR2018BB024)
  • Traditional Chinese Medicine Technology Development Foundation of Shandong (2019-0521)
  • Science and Technology Development Foundation of Binzhou (2015ZC0304)
  • Research Foundation of Binzhou Medical University (BY2015KYQD31, BY2017KJ17)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
Keywords
aaptamine, Alzheimer's disease, acetylcholinesterase inhibition, butyrylcholinesterase inhibition, dual cholinesterase inhibitors, marine sponge natural products, zebrafish model, donepezil, mixed-type inhibition, enzyme kinetics, anti-Alzheimer drug candidates
MeSH terms
Donepezil, Acetylcholinesterase, Alzheimer Disease, Animals, Butyrylcholinesterase, Cholinesterase Inhibitors, Humans, Kinetics, Naphthyridines, Zebrafish, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent. https://app.cochat.ai/papers/10.1080/13880209.2022.2102657
The paper
Miao, S., He, Q., Li, C., Wu, Y., Liu, M., Chen, Y., Qi, S., & Gong, K. (2022). Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent. Pharmaceutical Biology. https://doi.org/10.1080/13880209.2022.2102657

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.